enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Metachromatic leukodystrophy - Wikipedia

    en.wikipedia.org/wiki/Metachromatic_leukodystrophy

    The incidence of metachromatic leukodystrophy is estimated to occur in 1 in 40,000 to 1 in 160,000 individuals worldwide. [13] There is a much higher incidence in certain genetically isolated populations, such as 1 in 75 in Habbanites (a small group of Jews who immigrated to Israel from southern Arabia), 1 in 2,500 in the western portion of the ...

  3. Atidarsagene autotemcel - Wikipedia

    en.wikipedia.org/wiki/Atidarsagene_autotemcel

    Atidarsagene autotemcel, sold under the brand name Libmeldy among others, is a gene therapy treatment for metachromatic leukodystrophy developed by Orchard Therapeutics.It contains an autologous CD34⁺ cell enriched population that contains haematopoietic stem and progenitor cells transduced using a lentiviral vector encoding the human arylsulfatase A (ARSA) gene.

  4. Dr. Jeff Hersh: FDA has just approved new treatment for ... - AOL

    www.aol.com/dr-jeff-hersh-fda-just-091822142.html

    A new medical treatment that costs more than $4 million for metachromatic leukodystrophy (MLD) was approved recently by the FDA. MLD was recognized as a disease in the early 1900s, although ...

  5. Leukodystrophy - Wikipedia

    en.wikipedia.org/wiki/Leukodystrophy

    Krabbe disease and metachromatic leukodystrophy (MLD) are two of such type. MLD is found on human chromosome 22 at position q13.31. [15] Another type of inherited leukodystrophy is X-linked adrenoleukodystrophy (X-ALD). As its name implies, this type of leukodystrophy is the result of a mutation found on the X-chromosome. It is also carried in ...

  6. US approves first gene therapy for children with rare genetic ...

    www.aol.com/news/us-approves-first-gene-therapy...

    Orchard, which was acquired by Japanese pharmaceutical firm Kyowa Kirin for $477.6 million last year, said it will provide details on the pricing and availability of the therapy later in the week.

  7. Lysosomal storage disease - Wikipedia

    en.wikipedia.org/wiki/Lysosomal_storage_disease

    Type of defect protein Disease examples Deficient protein Lysosomal enzymes primarily: Tay–Sachs disease, I-cell disease, [7] Sphingolipidoses (e.g., Krabbe disease, gangliosidosis: Gaucher, Niemann–Pick disease and glycolipids: Metachromatic leukodystrophy), Lysosomal acid lipase deficiency

  8. Lipid storage disorder - Wikipedia

    en.wikipedia.org/wiki/Lipid_storage_disorder

    Many lipid storage disorders can be classified into the subgroup of sphingolipidoses, as they relate to sphingolipid metabolism. Members of this group include Niemann-Pick disease, Fabry disease, Krabbe disease, Gaucher disease, Tay–Sachs disease, metachromatic leukodystrophy, multiple sulfatase deficiency, and Farber disease.

  9. Sphingolipidoses - Wikipedia

    en.wikipedia.org/wiki/Sphingolipidoses

    The main members of this group are Niemann–Pick disease, Fabry disease, Krabbe disease, Gaucher disease, Tay–Sachs disease and metachromatic leukodystrophy. They are generally inherited in an autosomal recessive fashion, but notably Fabry disease is X-linked recessive.